The resurgence of whooping cough is an ongoing concern in the U.S., and this week the FDA cleared Adacel as first Tdap vaccine for repeat vaccination. Plus, Cabometyx gains a new use in aggressive liver cancer. Researchers at Georgia Tech are using microneedle techniques to develop birth control, and a reality check on cervical cancer screening is posted. Finally, first-time generics, like Teva’s newly approved seizure drug vigabatrin, are a top FDA priority.
top of page
bottom of page